Mycobacterium tuberculosis (Mtb) remains a global health problem worsened by the increasing prevalence of multi-drug (MDR) and extensively drug resistant (XDR) strains and co-infection with HIV. Recently, the persistence phenotype of Mtb, which allows the microbe to effectively evade the host immune response and 'persist'amid long-term drug treatment, has garnered much attention as being the single biggest impediment to tuberculosis (TB) control. Persistence makes Mtb an extremely effective pathogen and difficult to control. The theme of this proposal for the last 25 years has been to isolate mutants of Mtb to probe the biological mechanisms associated with TB pathogenesis and drug resistance. We propose to extend this theme by genetically analyzing mechanisms of persistence. Based on our recent discovery that Mtb can induce DNA nets in human macrophages, we postulate that persistence in vivo can be the result of extracellular Mtb growing in pellicles or biofilms in vivo. We plan to test this hypothesis with mutant Mtb cells and a novel Persister reporter Phage (PRP) that we have developed to identify persister Mtb cells. We have isolated novel classes of mutants Mtb that fail to persist in macrophages, and we plan to explore their biology using a combination of transcriptomic and metabolomic analyses. Lastly, using a saturating transposon mutagenesis method, we have discovered a novel succinate dehydrogenate activity required for resisting killing by the combination of Isoniazid and Rifampicin. Preliminary data suggests that this mutation causes an inability to regulate respiration which converges with our recent discovery that Vitamin C can kill persister Mtb cells. We intend to further expand these concepts and test their relevance in mouse models. Knowledge of the biological mechanisms of persistence should lead to better diagnostics, better immunotherapies and better chemotherapies.

Public Health Relevance

Tuberculosis (TB) remains a global health threat, particularly with the recent emergence of strains that are resistant to all 10 anti-TB drugs. Mycobacterium tuberculosis (Mtb), the causative agent of TB, has evolved mechanisms to persist - a physiological response to resist killing. This proposal will use a multidisciplinary proposal combines mycobacterial genetics, transcriptomics, metabolomics and mouse models to study the persistence phenotype of Mtb. Knowledge gained should lead to improved diagnostics, more effective vaccines, and better chemotherapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI026170-26A1
Application #
8698045
Study Section
Bacterial Pathogenesis Study Section (BACP)
Program Officer
Lacourciere, Karen A
Project Start
1988-12-01
Project End
2019-02-28
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
26
Fiscal Year
2014
Total Cost
$724,867
Indirect Cost
$231,227
Name
Albert Einstein College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
110521739
City
Bronx
State
NY
Country
United States
Zip Code
10461
Yang, Yong; Thomas, Joseph; Li, Yunlong et al. (2017) Defining a temporal order of genetic requirements for development of mycobacterial biofilms. Mol Microbiol 105:794-809
Stratton, Thomas P; Perryman, Alexander L; Vilchèze, Catherine et al. (2017) Addressing the Metabolic Stability of Antituberculars through Machine Learning. ACS Med Chem Lett 8:1099-1104
Prados-Rosales, Rafael; Carreño, Leandro; Cheng, Tingting et al. (2017) Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine. PLoS Pathog 13:e1006250
Saito, Kohta; Warrier, Thulasi; Somersan-Karakaya, Selin et al. (2017) Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations. Proc Natl Acad Sci U S A 114:E4832-E4840
Hanauer, David I; Graham, Mark J; SEA-PHAGES et al. (2017) An inclusive Research Education Community (iREC): Impact of the SEA-PHAGES program on research outcomes and student learning. Proc Natl Acad Sci U S A 114:13531-13536
Kerantzas, Christopher A; Jacobs Jr, William R (2017) Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application. MBio 8:
Vilchèze, Catherine; Hartman, Travis; Weinrick, Brian et al. (2017) Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 114:4495-4500
Glass, Lisa N; Swapna, Ganduri; Chavadi, Sivagami Sundaram et al. (2017) Mycobacterium tuberculosis universal stress protein Rv2623 interacts with the putative ATP binding cassette (ABC) transporter Rv1747 to regulate mycobacterial growth. PLoS Pathog 13:e1006515
Jensen, Kara; Dela Pena-Ponce, Myra Grace; Piatak Jr, Michael et al. (2017) Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG Vaccine. Clin Vaccine Immunol 24:
Olsen, Aaron; Chen, Yong; Ji, Qingzhou et al. (2016) Targeting Mycobacterium tuberculosis Tumor Necrosis Factor Alpha-Downregulating Genes for the Development of Antituberculous Vaccines. MBio 7:

Showing the most recent 10 out of 84 publications